CTLA-4 Genetic Variants Predict Survival in Patients with Sepsis.

J Clin Med · 2019 · PMC6352177 · PMID 30634576

Europe PMC DOI

hedged sentence

0.0002

closest p · 0.0× alpha

0.0002

boldest claim

The sentences

highly significantp = 0.0002actually significant

The H1: TAA noncarriers showed highly significant higher average procalcitonin levels (5.1 ± 9.7 ng/dL vs. 3.5 ± 9.1 ng/dL; p = 0.0002) as well as significantly lower urine outputs (2792 ± 1242 mL/day vs. 3060 ± 1370 mL/day; p = 0.0229) over the observation period than the H1: TAA-positive patients. 4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.